Mortality in members of HIV-1 serodiscordant couples in Africa and implications for antiretroviral therapy initiation: results of analyses from a multicenter randomized trial

scientific article

Mortality in members of HIV-1 serodiscordant couples in Africa and implications for antiretroviral therapy initiation: results of analyses from a multicenter randomized trial is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1033581389
P356DOI10.1186/1471-2334-12-277
P932PMC publication ID3582549
P698PubMed publication ID23130818
P5875ResearchGate publication ID232960363

P50authorAmalia S MagaretQ87912727
Jared M BaetenQ89443633
Jairam R LingappaQ89741329
Patrick NdaseQ117265888
Guy de BruynQ40494331
Anna WaldQ41122225
Connie CelumQ42571941
Partners in Prevention HSV/HIV Transmission Study TeamQ42572226
P2860cites workHuman immunodeficiency virus type 1 RNA level and CD4 count as prognostic markers and surrogate end points: a meta-analysis. HIV Surrogate Marker Collaborative GroupQ74213228
Mortality in HIV-infected Ugandan adults receiving antiretroviral treatment and survival of their HIV-uninfected children: a prospective cohort studyQ38876606
Gender and the use of antiretroviral treatment in resource-constrained settings: findings from a multicenter collaborationQ38876759
Levels and causes of adult mortality in rural South Africa: the impact of AIDS.Q39077610
Risk factors for domestic violence: findings from a South African cross-sectional studyQ39105497
Mortality and burden of disease in a cohort of HIV-seropositive adults in Nairobi, KenyaQ40538841
The impact of HIV/AIDS on mortality and household mobility in rural TanzaniaQ42661420
Mortality in siblings of patients coinfected with HIV and hepatitis C virusQ43034734
HIV incidence and HIV-associated mortality in a cohort of factory workers and their spouses in Tanzania, 1991 through 1996.Q43613351
Immunodeficiency and the risk of death in HIV infectionQ44506022
Effect of HIV/AIDS-related mortality on household dependency ratios in rural South Africa, 2000-2005.Q44919897
Socioeconomic disparities in access to HIV/AIDS treatment programs in resource-limited settingsQ45370055
Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countriesQ46391119
Prevention of HIV-1 infection with early antiretroviral therapyQ24634688
Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studiesQ24656950
Mortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa: comparison with HIV-unrelated mortalityQ28475331
Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study GroupQ29614934
Regional differences in prevalence of HIV-1 discordance in Africa and enrollment of HIV-1 discordant couples into an HIV-1 prevention trialQ33313869
Characteristics of HIV-1 discordant couples enrolled in a trial of HSV-2 suppression to reduce HIV-1 transmission: the partners studyQ33436735
Coming home to die? The association between migration and mortality in rural South AfricaQ33470693
Estimating the impact of plasma HIV-1 RNA reductions on heterosexual HIV-1 transmission riskQ33697958
Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2.Q33727305
Effect of early versus deferred antiretroviral therapy for HIV on survivalQ33789114
Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trialQ33881449
Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART studyQ34011661
Body mass index and risk of tuberculosis and deathQ34713831
Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infectionQ34740804
Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per microL in Europe and North America: a pooled cohort observational studyQ34903835
Confounding by indication in non-experimental evaluation of vaccine effectiveness: the example of prevention of influenza complicationsQ35013711
Early versus standard antiretroviral therapy for HIV-infected adults in HaitiQ36914021
Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysisQ37718319
Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from UgandaQ38869763
P275copyright licenseCreative Commons Attribution 2.0 GenericQ19125117
P6216copyright statuscopyrightedQ50423863
P921main subjectmulticenter clinical trialQ6934595
anti-retroviral agentQ50430310
P304page(s)277
P577publication date2012-10-30
P1433published inBMC Infectious DiseasesQ15759919
P1476titleMortality in members of HIV-1 serodiscordant couples in Africa and implications for antiretroviral therapy initiation: results of analyses from a multicenter randomized trial
P478volume12